Global Transdermal Patch for Pain Relief Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ1028733 No. of Pages: 150 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global Transdermal Patch for Pain Relief market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period between 2021 and 2027.
This report studies the Transdermal Patch for Pain Relief market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Transdermal Patch for Pain Relief in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Lidocaine Patch
Diclofenac Patch
Indomethacin Patch
Fentanyl Patch
Peppermint Patch
Methyl Salicylate Patch
Capsaicin Patch
Other
Market Snapshot, By Application
OTC
Rx
Main Market Players Analyzed in this report, including:
Teva
Sanofi
Qizheng
Pfizer
Performance Health
Nichiban
Mylan
Lingrui
Laboratoires Genevrier
Johnson & Johnson
IBSA Group
Huarun 999
Hisamitsu
Haw Par
GSK
Endo
BLUE-EMU
The study objectives of this report are:
To study and analyze the global Transdermal Patch for Pain Relief market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Transdermal Patch for Pain Relief market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Transdermal Patch for Pain Relief manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Transdermal Patch for Pain Relief market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Transdermal Patch for Pain Relief submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Transdermal Patch for Pain Relief are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Transdermal Patch for Pain Relief Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Transdermal Patch for Pain Relief Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Transdermal Patch for Pain Relief
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Transdermal Patch for Pain Relief Sales Channel and Distributors Analysis
3.3.1 Transdermal Patch for Pain Relief Sales Channel
3.3.2 Transdermal Patch for Pain Relief Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in OTC
3.4.2 Major Buyers in Rx
3.5 Transdermal Patch for Pain Relief Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Transdermal Patch for Pain Relief Type Introduction
4.1.1 Lidocaine Patch
4.1.2 Diclofenac Patch
4.1.3 Indomethacin Patch
4.1.4 Fentanyl Patch
4.1.5 Peppermint Patch
4.1.6 Methyl Salicylate Patch
4.1.7 Capsaicin Patch
4.1.8 Other
4.2 Global Transdermal Patch for Pain Relief Sales by Type 2016-2021
4.3 Global Transdermal Patch for Pain Relief Revenue by Type 2016-2021
4.4 Global Transdermal Patch for Pain Relief Price by Type 2016-2021
5 Market Segment: by Application
5.1 Transdermal Patch for Pain Relief Type Introduction
5.1.1 OTC
5.1.2 Rx
5.2 Global Transdermal Patch for Pain Relief Sales by Application 2016-2021
5.3 Global Transdermal Patch for Pain Relief Revenue by Application 2016-2021
5.4 Global Transdermal Patch for Pain Relief Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Transdermal Patch for Pain Relief Market by Region
6.1.1 Global Transdermal Patch for Pain Relief Sales by Regions
6.1.2 Global Transdermal Patch for Pain Relief Revenue by Regions
6.2 North America Transdermal Patch for Pain Relief Market 2016-2021
6.3 Europe Transdermal Patch for Pain Relief Market 2016-2021
6.4 Asia Pacific Transdermal Patch for Pain Relief Market 2016-2021
6.5 South America Transdermal Patch for Pain Relief Market 2016-2021
6.6 Middle East and Africa Transdermal Patch for Pain Relief Market 2016-2021
7 North America
7.1 North America Transdermal Patch for Pain Relief Market by Country 2016-2021
7.1.1 North America Transdermal Patch for Pain Relief Sales by Country
7.1.2 North America Transdermal Patch for Pain Relief Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Transdermal Patch for Pain Relief Market by Country 2016-2021
8.1.1 Europe Transdermal Patch for Pain Relief Sales by Country
8.1.2 Europe Transdermal Patch for Pain Relief Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Transdermal Patch for Pain Relief Market by Country 2016-2021
9.1.1 Asia Pacific Transdermal Patch for Pain Relief Sales by Country
9.1.2 Asia Pacific Transdermal Patch for Pain Relief Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Transdermal Patch for Pain Relief Market by Country 2016-2021
10.1.1 South America Transdermal Patch for Pain Relief Sales by Country
10.1.2 South America Transdermal Patch for Pain Relief Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Transdermal Patch for Pain Relief Market by Country 2016-2021
11.1.1 Middle East and Africa Transdermal Patch for Pain Relief Sales by Country
11.1.2 Middle East and Africa Transdermal Patch for Pain Relief Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Teva
12.1.1 Teva
Company Information
12.1.2 Teva
Transdermal Patch for Pain Relief Product Portfolio, Specification and Application
12.1.3 Teva
Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Teva
Key Development
12.2 Sanofi
12.2.1 Sanofi
Company Information
12.2.2 Sanofi
Transdermal Patch for Pain Relief Product Portfolio, Specification and Application
12.2.3 Sanofi
Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Sanofi
Key Development
12.3 Qizheng
12.3.1 Qizheng
Company Information
12.3.2 Qizheng
Transdermal Patch for Pain Relief Product Portfolio, Specification and Application
12.3.3 Qizheng
Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Qizheng
Key Development
12.4 Pfizer
12.4.1 Pfizer
Company Information
12.4.2 Pfizer
Transdermal Patch for Pain Relief Product Portfolio, Specification and Application
12.4.3 Pfizer
Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Pfizer
Key Development
12.5 Performance Health
12.5.1 Performance Health
Company Information
12.5.2 Performance Health
Transdermal Patch for Pain Relief Product Portfolio, Specification and Application
12.5.3 Performance Health
Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Performance Health
Key Development
12.6 Nichiban
12.6.1 Nichiban
Company Information
12.6.2 Nichiban
Transdermal Patch for Pain Relief Product Portfolio, Specification and Application
12.6.3 Nichiban
Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Nichiban
Key Development
12.7 Mylan
12.7.1 Mylan
Company Information
12.7.2 Mylan
Transdermal Patch for Pain Relief Product Portfolio, Specification and Application
12.7.3 Mylan
Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Nichiban
Key Development
12.9 Laboratoires Genevrier
12.9.1 Laboratoires Genevrier
Company Information
12.9.2 Laboratoires Genevrier
Transdermal Patch for Pain Relief Product Portfolio, Specification and Application
12.9.3 Laboratoires Genevrier
Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Laboratoires Genevrier
Key Development
12.8 Lingrui
12.8.1 Lingrui
Company Information
12.8.2 Lingrui
Transdermal Patch for Pain Relief Product Portfolio, Specification and Application
12.8.3 Lingrui
Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Lingrui
Key Development
12.11 IBSA Group
12.11.1 IBSA Group
Company Information
12.11.2 IBSA Group
Transdermal Patch for Pain Relief Product Portfolio, Specification and Application
12.11.3 IBSA Group
Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 IBSA Group
Key Development
12.12 Huarun 999
12.12.1 Huarun 999
Company Information
12.12.2 Huarun 999
Transdermal Patch for Pain Relief Product Portfolio, Specification and Application
12.12.3 Huarun 999
Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Huarun 999
Key Development
12.13 Hisamitsu
12.13.1 Hisamitsu
Company Information
12.13.2 Hisamitsu
Transdermal Patch for Pain Relief Product Portfolio, Specification and Application
12.13.3 Hisamitsu
Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 Hisamitsu
Key Development
12.14 Haw Par
12.14.1 Haw Par
Company Information
12.14.2 Haw Par
Transdermal Patch for Pain Relief Product Portfolio, Specification and Application
12.14.3 Haw Par
Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Haw Par
Key Development
12.15 GSK
12.15.1 GSK
Company Information
12.15.2 GSK
Transdermal Patch for Pain Relief Product Portfolio, Specification and Application
12.15.3 GSK
Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2019-2021)
12.15.4 GSK
Key Development
12.17 BLUE-EMU
13 Global Transdermal Patch for Pain Relief Market Forecast by Region by Type and by Application
13.1 Global Transdermal Patch for Pain Relief Sales, Revenue Forecast 2022-2027
13.2 Global Transdermal Patch for Pain Relief Forecast by Regions
13.2.1 Global Transdermal Patch for Pain Relief Sales Forecast by Region 2022-2027
13.2.2 Global Transdermal Patch for Pain Relief Revenue Forecast by Region 2022-2027
13.3 Global Transdermal Patch for Pain Relief Forecast by Type
13.3.1 Global Transdermal Patch for Pain Relief Sales Forecast by Type 2022-2027
13.3.2 Global Transdermal Patch for Pain Relief Revenue Forecast by Type 2022-2027
13.3.3 Global Transdermal Patch for Pain Relief Price Forecast by Type 2022-2027
13.4 Global Transdermal Patch for Pain Relief Forecast by Application
13.4.1 Global Transdermal Patch for Pain Relief Sales Forecast by Application 2022-2027
13.4.2 Global Transdermal Patch for Pain Relief Revenue Forecast by Application 2022-2027
13.4.3 Global Transdermal Patch for Pain Relief Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com